Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PD-1 Antibodies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03523819
What this trial is testing

CS1002 in Subjects with Advanced Solid Tumors

Who this might be right for
Solid Tumor, Adult
CStone Pharmaceuticals 91
Large-scale testing (Phase 3)Looking for participantsNCT06246916
What this trial is testing

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

Who this might be right for
Melanoma
Regeneron Pharmaceuticals 560
Very early researchLooking for participantsNCT07598578
What this trial is testing

An Open-label, Single-arm, Multicenter Phase II Clinical Study of Azacitidine, Chidamide Combined With PD-1 Monoclonal Antibody in the Treatment of Refractory/Relapsed Peripheral T-cell Lymphoma.

Who this might be right for
Peripheral T-Cell Lymphoma Refractory
Second Affiliated Hospital of Soochow University 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT04379739
What this trial is testing

Neoadjuvant PD-1 Antibody Plus Apatinib or Chemotherapy for Non-small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China 89
Not applicableLooking for participantsNCT05707819
What this trial is testing

Sintilimab in Combination With Chemoradiotherapy in High-risk Locoregionally-advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CarcinomaSintilimab
Cancer Hospital of Guangxi Medical University 43
Early research (Phase 1)Active Not RecruitingNCT04042701
What this trial is testing

DS8201a and Pembrolizumab in Participants With Locally Advanced/Metastatic Breast or Non-Small Cell Lung Cancer

Who this might be right for
Breast CancerNon-small Cell Lung Carcinoma
Daiichi Sankyo 115
Testing effectiveness (Phase 2)Ended earlyNCT01420965
What this trial is testing

Sipuleucel-T, CT-011, and Cyclophosphamide for Advanced Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Augusta University 7
Not applicableUnknownNCT02938728
What this trial is testing

Definition of an Immune Signature Predictive of Anti-PD1 (Programmed Death-1) Antibody in the Treatment of Advanced Melanoma

Who this might be right for
Malignant Melanoma
Assistance Publique - Hôpitaux de Paris 120
Testing effectiveness (Phase 2)UnknownNCT05216237
What this trial is testing

Evaluate the Efficacy and Safety of Sintilimab Plus Apatinib and Chemotherapy in Patients With HER-2 Negative Microsatellite Stability (MSS) Advanced or Metastatic Gastric (GC) or Gastroesophageal Junction (GEJ) Cancer

Who this might be right for
Gastric CancerChemotherapyImmunotherapy
Jiuda Zhao 31
Testing effectiveness (Phase 2)WithdrawnNCT03554395
What this trial is testing

Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Gastric Cancer

Who this might be right for
Advanced Gastric Cancer
Fuda Cancer Hospital, Guangzhou
Large-scale testing (Phase 3)Active Not RecruitingNCT04165317
What this trial is testing

Sasanlimab in People With Non-muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle Invasive Bladder Cancer
Pfizer 1,068
Testing effectiveness (Phase 2)Ended earlyNCT03476174
What this trial is testing

Anti-PD-1 Antibody With HD IL-2 in Metastatic Melanoma

Who this might be right for
Melanoma
Ralph Hauke 1
Large-scale testing (Phase 3)UnknownNCT03427827
What this trial is testing

PD-1 Antibody Versus Best Supportive Care After Chemoradiation in Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Neoplasms
Sun Yat-sen University 450
Early research (Phase 1)UnknownNCT03251313
What this trial is testing

PD-1(Programmed Death-1) Antibody +GP as First Line Treatment for Triple Negative Breast Cancer(TNBC) Patients

Who this might be right for
Triple Negative Breast Cancer
Fudan University 31
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07837362
What this trial is testing

SCRT Combined With CAPOX and PD-1/CTLA4 Antibody for Early-stage Low Rectal Cancer

Who this might be right for
Early Low Rectal Cancer
Fudan University 34
Not applicableUnknownNCT04322591
What this trial is testing

Chemotherapy or Chemotherapy Plus PD-1 Antibody in RET Fusion Positive Advanced NSCLC Patitnts: the POSEIDON Trial

Who this might be right for
Non-small Cell Lung Cancer
Hunan Province Tumor Hospital 70
Early research (Phase 1)WithdrawnNCT01386502
What this trial is testing

CT-011 and p53 Genetic Vaccine for Advanced Solid Tumors

Who this might be right for
Breast CancerColon CancerPancreatic Cancer+2 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)UnknownNCT05490719
What this trial is testing

A Phase II Study of CRT Combined With QL1706 in ESCC Patients

Who this might be right for
Esophageal Squamous Cell Carcinoma
Tianjin Medical University Cancer Institute and Hospital 39
Testing effectiveness (Phase 2)Study completedNCT04732494
What this trial is testing

Anti-PD-1 Monoclonal Antibody Tislelizumab (BGB-A317) Combined With or Without Anti-TIGIT Monoclonal Antibody Ociperlimab (BGB-A1217) in Participants With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
BeiGene 125
Early research (Phase 1)UnknownNCT03527251
What this trial is testing

Anti-CTLA-4 Antibody Followed by Anti-PD-1 Antibody in Recurrent or Metastatic NSCLC

Who this might be right for
Non Small Cell Lung Cancer
Sun Yat-sen University 10
Next Page